NO994659D0 - Nye pyridinderivater og farmasöytiske preparater inneholdende slike - Google Patents

Nye pyridinderivater og farmasöytiske preparater inneholdende slike

Info

Publication number
NO994659D0
NO994659D0 NO994659A NO994659A NO994659D0 NO 994659 D0 NO994659 D0 NO 994659D0 NO 994659 A NO994659 A NO 994659A NO 994659 A NO994659 A NO 994659A NO 994659 D0 NO994659 D0 NO 994659D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preparations containing
pyridine derivatives
new pyridine
new
Prior art date
Application number
NO994659A
Other languages
English (en)
Other versions
NO994659L (no
Inventor
David Cheshire
David Cladingboel
Simon Hirst
Carol Manners
Michael Stocks
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9701100A external-priority patent/SE9701100D0/xx
Priority claimed from SE9702199A external-priority patent/SE9702199D0/xx
Priority claimed from SE9704403A external-priority patent/SE9704403D0/xx
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO994659D0 publication Critical patent/NO994659D0/no
Publication of NO994659L publication Critical patent/NO994659L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO994659A 1997-03-25 1999-09-24 Nye pyridinderivater og farmasöytiske preparater inneholdende slike NO994659L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9701100A SE9701100D0 (sv) 1997-03-25 1997-03-25 Novel compounds
SE9702199A SE9702199D0 (sv) 1997-06-09 1997-06-09 Novel compounds
SE9704403A SE9704403D0 (sv) 1997-11-28 1997-11-28 Novel compounds
PCT/SE1998/000505 WO1998042670A1 (en) 1997-03-25 1998-03-20 Novel pyridine derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
NO994659D0 true NO994659D0 (no) 1999-09-24
NO994659L NO994659L (no) 1999-11-25

Family

ID=27355863

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994659A NO994659L (no) 1997-03-25 1999-09-24 Nye pyridinderivater og farmasöytiske preparater inneholdende slike

Country Status (17)

Country Link
US (1) US6300352B1 (no)
EP (1) EP0971892A1 (no)
JP (1) JP2001518115A (no)
KR (1) KR20010005646A (no)
CN (1) CN1257481A (no)
AR (1) AR012157A1 (no)
AU (1) AU6530998A (no)
BR (1) BR9808042A (no)
CA (1) CA2284200A1 (no)
EE (1) EE9900426A (no)
ID (1) ID22660A (no)
IL (1) IL131846A0 (no)
NO (1) NO994659L (no)
PL (1) PL335905A1 (no)
SK (1) SK130599A3 (no)
TR (1) TR199902350T2 (no)
WO (1) WO1998042670A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6376524B1 (en) 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
US7335779B2 (en) * 2002-03-08 2008-02-26 Quonova, Llc Modulation of pathogenicity
US7338969B2 (en) * 2002-03-08 2008-03-04 Quonova, Llc Modulation of pathogenicity
US7153889B2 (en) * 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
US20040092521A1 (en) * 2002-11-12 2004-05-13 Altenbach Robert J. Bicyclic-substituted amines as histamine-3 receptor ligands
CA2765093A1 (en) * 2002-11-12 2004-05-27 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
US20070093534A1 (en) * 2003-05-06 2007-04-26 Aldo Ammendola Modulation of Pathogenicity
EP1778214A4 (en) * 2004-07-27 2010-04-14 Glaxosmithkline Llc NEW BIPHENYL COMPOUNDS AND THEIR USE
US7498049B1 (en) * 2007-01-03 2009-03-03 Shmuel Gonen Topical treatment of acne with combined herbal extracts and minerals
DK3307262T3 (da) * 2015-06-15 2021-08-09 Nmd Pharma As Forbindelser til anvendelse ved behandling af neuromuskulære lidelser
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
CN114989114A (zh) * 2022-06-02 2022-09-02 杭州福斯特电子材料有限公司 一种n-丙烯酰吗啉的合成方法及光固化组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0267439A3 (en) * 1986-10-14 1988-08-31 G.D. Searle & Co. Alpha-(phenylalkyl) pyridinealkanol derivatives
AU7975887A (en) * 1986-10-16 1988-04-21 G.D. Searle & Co. Alpha-((phenylmethoxy)methyl)pyridine alkanols
WO1997020815A1 (en) * 1995-12-06 1997-06-12 Astra Pharmaceuticals Ltd. Compounds

Also Published As

Publication number Publication date
WO1998042670A1 (en) 1998-10-01
CA2284200A1 (en) 1998-10-01
NO994659L (no) 1999-11-25
TR199902350T2 (xx) 2000-04-21
BR9808042A (pt) 2000-03-08
US6300352B1 (en) 2001-10-09
SK130599A3 (en) 2000-05-16
PL335905A1 (en) 2000-05-22
CN1257481A (zh) 2000-06-21
AR012157A1 (es) 2000-09-27
JP2001518115A (ja) 2001-10-09
ID22660A (id) 1999-12-02
EP0971892A1 (en) 2000-01-19
KR20010005646A (ko) 2001-01-15
AU6530998A (en) 1998-10-20
EE9900426A (et) 2000-04-17
IL131846A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
NO305316B1 (no) Nye substituerte 1H-imidazoler og farmas°ytiske preparater inneholdende disse
NO307827B1 (no) Benzoksazol- og pyridinderivater, anvendelse av dem og farmasøytisk preparat inneholdende dem
IS4644A (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
NO308298B1 (no) Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem
NO993868D0 (no) 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
IS4345A (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
NO930517D0 (no) Benzimidazolylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
NO20011157L (no) Benzenderivater og farmasöytisk anvendelse derav
NO307092B1 (no) Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding
NO984309L (no) Nye imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse
DK130389D0 (da) Catecholderivater og farmaceutiske praeparater omfatende samme
NO994659D0 (no) Nye pyridinderivater og farmasöytiske preparater inneholdende slike
NO960722D0 (no) Benzazepinderivat, farmasöytisk preparat inneholdende dette, og mellomprodukter for dette
NO934372D0 (no) Nye forbindelser og farmas!ytisk preparat derav
NO20006576D0 (no) Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette
NO981241D0 (no) Heteroarylsubstituerte akryloylguanidinderivater og farmasöytiske preparater inneholdende disse
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
DK0728739T3 (da) Biaromatiske amidderivater, farmaceutiske og kosmetiske præparater, der indeholder dem, og deres anvendelse
NO940710D0 (no) Nye Esculetin-derivater og farmasöytisk blanding
NO994764D0 (no) Nye pyridinderivater og farmasöytiske preparater inneholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application